跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RADELUMIN 1300 MBQ/ML SOLUCION INYECTABLE - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
RADELUMIN 1300 MBQ/ML SOLUCION INYECTABLE
Approved
STANDARD
RADELUMIN 1300 MBQ/ML SOLUCION INYECTABLE
Abx Advanced Biochemical Compounds Biomedizinische Forschungsreagenzien Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
May 16, 2023
Approval ID
6e2916392e997a6a
Company
Abx Advanced Biochemical Compounds Biomedizinische Forschungsreagenzien Gmbh
Type
Standard
Approval Details
Approval Id
6e2916392e997a6a
Drug Cima Aemps Name
RADELUMIN 1300 MBQ/ML SOLUCION INYECTABLE
Register Number
88792
Holder Company Name
Abx Advanced Biochemical Compounds Biomedizinische Forschungsreagenzien Gmbh
Marketing Company Name
Abx Advanced Biochemical Compounds Biomedizinische Forschungsreagenzien Gmbh
Authorization Date
2023-05-16
Dosage Form
SOLUCIÓN INYECTABLE
Dose
1300 MBq/ml
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Abx Advanced Biochemical Compounds Biomedizinische Forschungsreagenzien Gmbh
Active Ingredients
PSMA-1007 (18F)
1300 MBq/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
May 16, 2023
Approval ID
6e2916392e997a6a
Type
Standard
Back to CIMA-AEMPS Approvals